Cargando…

Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer’s Disease and MCI: A Review

Alzheimer’s disease (AD) is a multifactorial, progressive, neurodegenerative disease typically characterized by memory loss, personality changes, and a decline in overall cognitive function. Usually manifesting in individuals over the age of 60, this is the most prevalent type of dementia and remain...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rao, Rammohan V., Subramaniam, Kaavya G., Gregory, Julie, Bredesen, Aida L., Coward, Christine, Okada, Sho, Kelly, Lance, Bredesen, Dale E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865291/ https://www.ncbi.nlm.nih.gov/pubmed/36675177 http://dx.doi.org/10.3390/ijms24021659

Ejemplares similares

ReCODE: A Personalized, Targeted, Multi-Factorial Therapeutic Program for Reversal of Cognitive Decline
por: Rao, Rammohan V, et al.
Publicado: (2021)

Reversal of cognitive decline: A novel therapeutic program
por: Bredesen, Dale E.
Publicado: (2014)

Reversal of cognitive decline in Alzheimer's disease
por: Bredesen, Dale E., et al.
Publicado: (2016)

Neuroprotective Herbs for the Management of Alzheimer’s Disease
por: Gregory, Julie, et al.
Publicado: (2021)

Ayurvedic medicinal plants for Alzheimer's disease: a review
por: Rao, Rammohan V, et al.
Publicado: (2012)

Inhalational Alzheimer's disease: an unrecognized—and treatable—epidemic
por: Bredesen, Dale E.
Publicado: (2016)

Neurodegeneration in Alzheimer's disease: caspases and synaptic element interdependence
por: Bredesen, Dale E
Publicado: (2009)

Metabolic profiling distinguishes three subtypes of Alzheimer's disease
por: Bredesen, Dale E.
Publicado: (2015)

Next generation therapeutics for Alzheimer's disease
por: Bredesen, Dale E, et al.
Publicado: (2013)

Dynamic self-guiding analysis of Alzheimer's disease
por: Kurakin, Alexei, et al.
Publicado: (2015)

Alzheimer’s disease as a systems network disorder: chronic stress/dyshomeostasis, innate immunity, and genetics
por: Kurakin, Alexei, et al.
Publicado: (2020)

mCiRNA—Synaptic Crystal Ball?
por: Bredesen, Dale
Publicado: (2012)

Alzheimer’s Model Develops Early ADHD Syndrome
por: Zhang, Qiang, et al.
Publicado: (2015)

Inflammatory pathway analytes predicting rapid cognitive decline in MCI stage of Alzheimer’s disease
por: Pillai, Jagan A., et al.
Publicado: (2020)

Valosin-Containing Protein Gene Mutations: Cellular Phenotypes Relevant to Neurodegeneration
por: Poksay, Karen S., et al.
Publicado: (2011)

Human Bcl-2 Reverses Survival Defects in Yeast Lacking Superoxide Dismutase and Delays Death of Wild-Type Yeast
por: Longo, Valter D., et al.
Publicado: (1997)

Improved prediction of critical residues for protein function based on network and phylogenetic analyses
por: Thibert, Boris, et al.
Publicado: (2005)

Metabolic syndrome biomarkers relate to rate of cognitive decline in MCI and dementia stages of Alzheimer’s disease
por: Pillai, Jagan A., et al.
Publicado: (2023)

The PDZ Domain as a Complex Adaptive System
por: Kurakin, Alexei, et al.
Publicado: (2007)

Human Embryonic Stem Cells Express Elevated Levels of Multiple Pro-Apoptotic BCL-2 Family Members
por: Madden, David T., et al.
Publicado: (2011)

Correction: Human Embryonic Stem Cells Express Elevated Levels of Multiple Pro-Apoptotic BCL-2 Family Members
por: Madden, David T., et al.
Publicado: (2012)

DNA sequence models of genome-wide Drosophila melanogaster Polycomb binding sites improve generalization to independent Polycomb Response Elements
por: Bredesen, Bjørn André, et al.
Publicado: (2019)

MOCCA: a flexible suite for modelling DNA sequence motif occurrence combinatorics
por: Bredesen, Bjørn André, et al.
Publicado: (2021)

Increased intermediate M1-M2 macrophage polarization and improved cognition in mild cognitive impairment patients on ω-3 supplementation
por: Famenini, Sam, et al.
Publicado: (2017)

Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease
por: Spilman, Patricia, et al.
Publicado: (2010)

Efficient Identification of Critical Residues Based Only on Protein Structure by Network Analysis
por: Cusack, Michael P., et al.
Publicado: (2007)

Association of Anxiety Awareness with Risk Factors of Cognitive Decline in MCI
por: Gigi, Ariela, et al.
Publicado: (2021)

Key inflammatory pathway activations in the MCI stage of Alzheimer’s disease
por: Pillai, Jagan A., et al.
Publicado: (2019)

Correction: Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease
por: Spilman, Patricia, et al.
Publicado: (2011)

Correction: Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease
por: Spilman, Patricia, et al.
Publicado: (2011)

Gnocis: An integrated system for interactive and reproducible analysis and modelling of cis-regulatory elements in Python 3
por: Bredesen-Aa, Bjørn André, et al.
Publicado: (2022)

A Novel Motif Identified in Dependence Receptors
por: del Rio, Gabriel, et al.
Publicado: (2007)

Flux-Reducing Tendency of Pd-Based Membranes Employed in Butane Dehydrogenation Processes
por: Peters, Thijs A., et al.
Publicado: (2020)

Altering APP Proteolysis: Increasing sAPPalpha Production by Targeting Dimerization of the APP Ectodomain
por: Libeu, Clare A. Peters, et al.
Publicado: (2012)

Direction of Information Flow in Alzheimer's Disease and MCI Patients
por: Vecchio, Fabrizio, et al.
Publicado: (2011)

Neuropsychological comparison of incident MCI and prevalent MCI
por: Hansen, Allison, et al.
Publicado: (2018)

Precision Medicine Approach to Alzheimer’s Disease: Successful Pilot Project
por: Toups, Kat, et al.
Publicado: (2022)

Biomarker-Based Signature of Alzheimer’s Disease in Pre-MCI Individuals
por: Chipi, Elena, et al.
Publicado: (2019)

Patient and organisational variables associated with pressure ulcer prevalence in hospital settings: a multilevel analysis
por: Bredesen, Ida Marie, et al.
Publicado: (2015)

In Brief Neuropsychological Assessment, Amnestic Mild Cognitive Impairment (MCI) Is associated with Cerebrospinal Fluid Biomarkers for Cognitive Decline in Contrast to the Prevailing NIA-AA MCI Criterion
por: Hessen, Erik, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hiad6qjfttfk9binh6rdlou8ep